Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Daily Grime - SGR/EQLS

Published 26/09/2019, 11:32
Updated 09/07/2023, 11:32

Shore Capital is to cancel it AIM listing as it believes the lack of liquidity results in a mispricing of its shares while the costs are high. The company will maintain its listing in Bermuda to enable shareholders to continue to hold shares in their ISA. 75% approval required. I wonder how many more of these we will see with the increased aversion to small and illiquid companies

Equals Group (LON:EQLS) – H1 Results

Share Price 99pMkt Cap £177mConflict Disclosure: No Holding
  • Results. Revenue up 21% to £14.6m. EBITDA up 78% to £4.7m. This 32% EBITDA margin. One off costs were significant such as a marketing rebrand costing £725k so adjusted PAT was only modestly ahead after higher depreciation charges and amortisation. EPS was down slightly at 1.72p (2018 1.79p) as more shares were in issue. Currency transactions are still 85% of revenue with the balance coming from banking transactions while corporate customers are now 68% of revenue. The outlook shows H2 revenues up 18% while a global citi group partnership has been entered into and a revolving credit facility product is in beta testing as well as Hermes FX being acquired. “Confident” of meeting market expectations
  • Estimates FY EBITDA is expected to be £11.6m. PBT £10.9m and EPS 6.2p. No dividend yet.
  • Valuation 2019 PER 16X, falling to 13.6X 2020, based on 18% undelying growth.
  • Conclusion These results read like a Monzo or Revolut with the new products coming onstream alongside the recent fund raise enabling further acquisitions. Except it is profitable and on a PE of 16X. I can’t see a reason the shares aren’t more highly rated other than people remember a downgrade a few years ago when the profitability point was moved to the right.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Shore Capital (LON:SGRS) – H1 Results

Share Price 185p

Mkt Cap £40m

Conflict Disclosure: No Holding

  • Results Revenue up 12% to £24.3m, PBT up 7.5% to £2.7m. EPS excluding Stockdale re organisation up 33% to 9.9p and statutory EPS down 31% to 5.1p. Dividend 5p. The company now has 123 corporate clients having added 52 from the acquisition of Stockdale. Capital markets made £2.7m before re organisation costs while Asset Management made £1.5m from the £1bn of AUM. While Principal Finance lost 452k. Central costs were £1m.
  • Estimates None
  • Valuation PER 14.5X last year’s earnings. This could fall to 10X this year but there are no formal forecasts. NAV is £66m compared to a market cap of £40m..
  • Conclusion The company is de-listing just as the prospects look brighter. This could be the start of a trend. I am sad about that.

    Latest comments

    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
    Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
    Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
    It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
    Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
    © 2007-2024 - Fusion Media Limited. All Rights Reserved.